BSD Medical Corp. (BSDM) Receives FDA 510(k) Clearance to Market MicroThermX Microwave Ablation System
BSD Medical Corp. develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. The company's product lines include systems to treat cancer that have been in use for several years in the United States, Europe and Asia. BSD Medical announced today that the US Food and Drug Administration (FDA) has granted the company a510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical…